Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Dermatology | Family Medicine
Clinical Trials: Rosacea
A listing of clinical trials currently looking for volunteers to enroll in Rosacea studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
California
Colorado
Denver : Horizons Clinical Research Center, LLC
Now enrolling for a clinical research study for the treatment of Rosacea.
Florida
Bradenton : Susan H. Weinkle, MD
A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea
Illinois
Chicago : Radiant Research - Chicago
Clinical Research Opportunity
View More »
Chicago : DeNova Research
A Double-Blinded, Randomized Placebo Controlled Pilot Study Comparing the Efficacy and Safety of IncobotulinumtoxinA Versus Saline Injections to the Cheek Region in Patients With Rosacea
Kentucky
Louisville : Dermatology Specialists Research, LLC
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
Richmond : Melissa L.F. Knuckles MD, PSC
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
Louisiana
New Orleans : Lupo Center for Aesthetic & General Dermatology
A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea
New York
New York : Diane Berson, MD
A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea
New York : Columbia University Medical Center
Open Label Pilot Study of Apremilast in Treatment of Rosacea
New York : Sadick Dermatology
Safety and Efficacy of the Luxe Device to Treat Facial Wrinkles and Rosacea
New York : New York Laser & Skin Care
Safety and Efficacy of the Luxe Device to Treat Facial Wrinkles and Rosacea
North Carolina
Hickory : PMG Research of Hickory
Are You Dealing With Red Pimply Skin? It Could Be Rosacea
Raleigh : Wake Research Associates
Study of Rosacea
Wilmington : PMG Research of Wilmington Updated
Do You Suffer From Facial Redness?
Winston Salem : PMG Research of Winston-Salem
Are You Dealing With Red Pimply Skin? It Could Be Rosacea
View More »
High Point : Zoe Draelos, MD Principal Investigator
Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea
South Carolina
Texas
Dallas : Research Across America
Rosacea Research Study
View More »
Austin : DermResearch, Inc
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
Virginia
Lynchburg : The Education & Research Foundation, Inc.
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
Canada
Victoria : Cosmedica
Ulthera System for the Treatment of Rosacea
Czech Republic
Chomutov : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Hradec Kralove : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Olomouc : Galderma Invetigational site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Pardubice : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Praha 1 : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
View More »
Slany : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
France
Bordeaux : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Brest : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Cannes : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Nice : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Saint Etienne : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Germany
Augsburg : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Bochum : Study site 5
Efficacy and Tolerability of Topical Rossoseq™ Compared to Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic)
Bonn : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Dresden : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Duelmen : Study site 2
Efficacy and Tolerability of Topical Rossoseq™ Compared to Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic)
View More »
Hamburg : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Mahlow : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Mainz : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Munich : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Munster : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Münster : Study Site 1
Efficacy and Tolerability of Topical Rossoseq™ Compared to Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic)
Paderborn : Study site 4
Efficacy and Tolerability of Topical Rossoseq™ Compared to Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic)
Tubingen : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Wiesbaden : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Wuppertal : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Hungary
Budapest : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Miskolc : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Szeged : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Szekszard : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Szolnok : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Israel
Tel-Aviv : Sourasky Medical Center
Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea Patients
Poland
Bialystok : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Gdansk : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Krakow : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Warszawa : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Wroclaw : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Romania
Brasov : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Bucharest : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Craiova : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Timisoara : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Tirgu Mures : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
United Kingdom
Berkshire : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Bexhill : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
London : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Nuneaton : Galderma Investigational Site
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study